Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Tnf-Inhibiting Antibodies
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 13 of these applications claim priority to application 61/993,907, filed May 15, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,039,810 | Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Anti-Interleukin Antibodies In force · High confidence UsedRemaining | Rani Therapeutics, LLC | In force | High confidence | ||
| US 10,058,595 | Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Tnf-Inhibiting Antibodies In force · High confidence | Rani Therapeutics, LLC | In force | High confidence | ||
| US 10,220,076 | Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Glucose Regulating Proteins In force · High confidence | Rani Therapeutics, LLC | In force | High confidence | ||
| US 10,227,403 | Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Polypeptides And/Or Proteins In force · Medium confidence | Rani Therapeutics, LLC | In force | Medium confidence | ||
| US 10,953,075 | Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Anti-Interleukin Antibodies In force · Low confidence | Rani Therapeutics, LLC | In force | Low confidence | ||
| US 11,026,998 | Shaped Mass Composition Comprising Exenatide In force · High confidence | Rani Therapeutics, LLC | In force | High confidence | ||
| US 11,304,993 | Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Polypeptides And/Or Proteins In force · Low confidence | Rani Therapeutics, LLC | In force | Low confidence | ||
| US 12,214,019 | Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Polypeptides And/Or Proteins In force · Medium confidence | Rani Therapeutics, LLC | In force | Medium confidence | ||
| US 10,689,460 | PCSK9 Antibody Preparations for Delivery into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · High confidence | Rani Therapeutics, LLC | In force | High confidence | ||
| US 11,718,665 | Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Polypeptides And/Or Proteins In force · High confidence | Rani Therapeutics, LLC | In force | High confidence | ||
| 7 more records in this group · Pro | ||||||
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17, including 1 expired.
13 of these are in force and held by Rani Therapeutics, LLC.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.